Pharmacy Benefit Managers (PBMs)

Centene Announces Expiration of Hart-Scott-Rodino Waiting Period with Respect to the Company’s Proposed Acquisition of Magellan Health Inc.

Centene Corporation (NYSE: CNC) has announced that as of 11:59 p.m. on March 12th, 2021, the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 with respect to the Company’s proposed acquisition of Magellan Health Inc. has expired. As previously announced on January 4, 2021, the transaction will broaden and deepen Centene’s whole health […]

Centene Announces Expiration of Hart-Scott-Rodino Waiting Period with Respect to the Company’s Proposed Acquisition of Magellan Health Inc. Read More »

PE-Backed Advanced Medical Pricing Solutions (AMPS) Expands Healthcare Cost Management Suite with Acquisition of Drexi

Advanced Medical Pricing Solutions (AMPS), a pioneer in healthcare cost management, is pleased to announce it has acquired Drexi, a pharmacy solution that enables savings by transparent pricing and pass-thru on prescription medications available at a nationwide network of more than 65,000 pharmacies. “This acquisition is part of AMPS’ strategic vision and growth plan to

PE-Backed Advanced Medical Pricing Solutions (AMPS) Expands Healthcare Cost Management Suite with Acquisition of Drexi Read More »

Southern Scripts Accelerates Expansion with Water Street Healthcare Partners

Southern Scripts announced today that it has received a capital commitment of $100 million from Water Street Healthcare Partners to expand its unique pharmacy benefit management (PBM) model that delivers significant savings to U.S. employers and maximizes members’ access to medications. Founded in 2011 by pharmacists dedicated to creating a truly different PBM model, Southern

Southern Scripts Accelerates Expansion with Water Street Healthcare Partners Read More »

Centene Signs Definitive Agreement to Acquire Magellan Health

Centene Corporation (NYSE: CNC) and Magellan Health, Inc. (NASDAQ: MGLN) today announced that they have entered into a definitive merger agreement under which Centene will acquire Magellan Health for $95 per share in cash for a total enterprise value of $2.2 billion. The transaction, which was unanimously approved by the Boards of Directors of both

Centene Signs Definitive Agreement to Acquire Magellan Health Read More »

RxAdvance’s Sculley: What the PBM of the Future Might Look Like

It’s not a secret that the healthcare industry is slow to change. The traditional models for pharmacy benefit managers have been under particular scrutiny of late, with these companies seeing the revival and finalization of the dreaded “rebate rule” and a Supreme Court ruling that could open the door for greater regulation. With these increasing

RxAdvance’s Sculley: What the PBM of the Future Might Look Like Read More »

US Supreme Court Rejects PBMs’ Challenge of State’s Ability to Regulate the Drug Middlemen

In a ruling that could pave the way for increased regulations by states such as Ohio, the U.S. Supreme Court on Thursday rejected a challenge of a 2015 Arkansas law putting restrictions on pharmacy benefit managers. “We have overwhelming evidence that the PBM marketplace is highly dysfunctional and exceedingly costly,” said Antonio Ciaccia, former lobbyist

US Supreme Court Rejects PBMs’ Challenge of State’s Ability to Regulate the Drug Middlemen Read More »

Scroll to Top